Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients.

Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology

PubMedID: 26207778

Atay D, Erbey F, Akcay A, Dag A, Ozturk G. Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients. J Pediatr Hematol Oncol. 2015;.
An abstract is not available. Please access the article through the links below.